Lucia Moiola

Department of Neurology, Multiple Sclerosis Center, IRCCS Ospedale San Raffaele

SCHOLARLY PAPERS

1

DOWNLOADS
Rank 46,115

SSRN RANKINGS

Top 46,115

in Total Papers Downloads

1,038

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis

Number of pages: 32 Posted: 08 Jul 2020
Department of Health Sciences (DISSAL), Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Department of Health Sciences, University of Genova, Department of Health Sciences, University of Genova, Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Department of Neurology, Multiple Sclerosis Center, IRCCS Ospedale San Raffaele, Department of Neurology and Multiple Sclerosis Center, ASST “Papa Giovanni XXIII, Multiple Sclerosis Center, Ospedale Guglielmo da Saliceto, Regional Referral Multiple Sclerosis Centre, Dept. of Neurology, University Hospital San Luigi, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Research Department, Italian Multiple Sclerosis Foundation, University of Campania “Luigi Vanvitelli” - First Division of Neurology, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Research Department, Italian Multiple Sclerosis Foundation, Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, University of Rome I - Department of Neuroscience, Mental Health and Sensory Organs and affiliation not provided to SSRN
Downloads 1,038 (23,350)
Citation 1

Abstract:

Loading...

Multiple Sclerosis; coronavirus; Immunomodulatory therapies; Immunosuppressive therapies